abstract |
The invention relates to at least one entity selected from compounds of formula (I) and pharmaceutically acceptable salts thereof, Wherein the variables X, R 1, R 2, R 3, m, n and p are as defined herein based. The invention also relates to a method for preparing at least one such entity and intermediates useful in its preparation, a pharmaceutical composition containing at least one such entity, at least one use of the entity in the preparation of a medicament, and at least one such entity in the treatment of allergies such as allergies Sexual diseases, autoimmune diseases, viral diseases and cancer. |